Eam Investors, LLC Kura Oncology, Inc. Transaction History

Eam Investors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$24.75 - $39.14 $1.45 Million - $2.29 Million	-58,409 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$29.0 - $41.62 $2.5 Million - $3.59 Million	-86,213 Reduced 59.61%	58,409 $1.91 Million
Q3 2020 Nov 13, 2020	BUY	$16.3 - $30.64 $2.36 Million - $4.43 Million	144,622 New	144,622 $4.43 Million
Q2 2018 Aug 03, 2018	SELL	$14.8 - $18.8 $1.16 Million - $1.47 Million	-78,146 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$14.5 - $23.4 $557,931 - $900,385	-38,478 Reduced 32.99%	78,146 $1.47 Million
Q4 2017 May 21, 2018	SELL	$13.5 - $16.65 $1.03 Million - $1.27 Million	-76,300 Reduced 39.55%	116,624 $1.78 Million
Q3 2017 Nov 08, 2017	BUY	$6.05 - $14.95 $1.17 Million - $2.88 Million	192,924	192,924 $2.88 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.